NCT05689879View on ClinicalTrials.gov

Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis

PHASE3RecruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions

Sarcoidosis

Interventions

DRUG

STOP arm

TNF-alpha antagonists withdrawal

Trial Locations (1)

75013

RECRUITING

Hôpital de la Pitié-Salpêtrière, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER